Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-27

FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Fluticasone Propionate and Salmeterol submitted by Teva Pharmaceuticals USA, Inc. The approval updates the product’s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone Propionate and Salmeterol (Fluticasone Propionate and Salmeterol)

Snippet

SUPPL AP for FLUTICASONE PROPIONATE AND SALMETEROL (FLUTICASONE PROPIONATE AND SALMETEROL)